← Open Payments lookup

STEPHEN POPKIN: Open Payments

NPI 1326004797 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$445 in 20 payments from 12 companies in 2025. Trend: 2023 $920 · 2024 $801 · 2025 $445

Food & beverage: $445
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$77
Lundbeck LLC3$62
ABBVIE INC.3$61
Takeda Pharmaceuticals U.S.A., Inc.2$53
E.R. Squibb & Sons, L.L.C.2$37
Alkermes, Inc.1$27
Tris Pharma Inc1$25
Bausch Health US, LLC1$25
Teva Pharmaceuticals USA, Inc.1$22
Vanda Pharmaceuticals Inc.1$22

Products named: REXULTI, CAPLYTA, VRAYLAR, TRINTELLIX, COBENFY, ARISTADA, Dyanavel XR, APLENZIN.

Industry payments across CO — which companies pay providers there.